Metabolic Dysfunction–Associated Steatotic Liver Disease, Alcohol Consumption, and the Risk of Atrial Fibrillation: A Nationwide Population‐Based Study
Background The recent reclassification of steatotic liver disease into metabolic dysfunction–associated steatotic liver disease (MASLD) and metabolic dysfunction‐associated alcohol‐related liver disease has highlighted their potential cardiovascular implications. This study aimed to investigate the...
Saved in:
| Main Authors: | Minkwan Kim, Minkook Son, Sang Yi Moon, Yang Hyun Baek |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Wiley
2025-07-01
|
| Series: | Journal of the American Heart Association: Cardiovascular and Cerebrovascular Disease |
| Subjects: | |
| Online Access: | https://www.ahajournals.org/doi/10.1161/JAHA.125.042003 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Impact of steatotic liver disease categories on atrial fibrillation in type 2 diabetes: a nationwide study
by: So Hyun Cho, et al.
Published: (2025-04-01) -
Impact of steatotic liver diseases on diabetes mellitus risk in patients with atrial fibrillation: a nationwide population study
by: Hyunho Ryu, et al.
Published: (2025-06-01) -
Metabolic dysfunction associated steatotic liver disease is associated with atrial fibrillation recurrence following cryoballoon ablation
by: Yu Wang, et al.
Published: (2025-02-01) -
Quantification of alcohol intake in patients with steatotic liver disease and excessive alcohol intake
by: Emil Deleuran Hansen, et al.
Published: (2025-01-01) -
Metabolic dysfunction-associated steatotic liver disease and increased risk of atrial fibrillation in the elderly: A longitudinal cohort study
by: Yehua Tang, et al.
Published: (2025-06-01)